Mywallst WallSt.net WallSt TV WallSt Radio
crwefinance.com's Blogs
Feb
08
Posted: 1 month(s) and 1 days(s) ago   |   0 Comment(s)   |   Rating: 0 0
Posted by: crwefinance.com

CRWEFinance.com Hot Stock News & Alerts!

________________________________________

crwefinancelogo2

FREE Daily Stock Alerts From CRWEFinance.com

 

signup3m

________________________________________

CRWEFinance.com Stock Report!

Be sure to check out more news at crwefinance.ning.com as well.

********************************************************************************

Power 3 Medical Products Inc. (PWRM.OB) is just one of those great companies with a name that speaks for itself. As an OTCBB company, it has been maintaining a volume of over a million almost every single day. The market has been in favor of this one for a while now and you should know more about them as well.

As you can see in the following chart, Power 3 Medical's 50- & 200-day MA's are in a positive direction, while the RSI is moving towards the underbought territory. You can find out more on Power 3 Medical at http://www.power3medical.com/default.aspx.


pwrm_0208

About Power3 Medical Products Inc.

Power3 Medical is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases. The research platform is centered on the study of proteomics, the science of protein interactions within living cells.

With a combined 50+ years of proteomic experience, the Company has identified 334 protein biomarkers with the following potential medical applications:

* Breast Cancer * Chemotherapeutic Drug Resistance
* Alzheimer's Disease * Leukemia
* ALS (Lou Gehrig's Disease) * Gastrointestinal Disease
* Parkinson's Disease * Metabolic Syndrome

These discovered and patent-pending biomarkers solve critical challenges facing pharmaceutical and diagnostic companies and are currently being used to design tests to diagnose diseases and discover targets for new drugs to treat the diseases.

pwrm

Editor-in Chief: Mandana Divanbeiki

***********Advertisement***********

stockir2

crweresearch

crwedomains

crwects

promolinks3

malonebailey

wfllc

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and has received an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and diseminate news and $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB).


   Member Rating: 0 0
Add Comment / Rating 
You need to Sign Up or Login to post a comment or rating 
Member Comments 
There are no member comments for this blog post.
Be the first to give your input.